MDKA Stock Overview
Engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Medika d.d. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €5,700.00 |
52 Week High | €7,700.00 |
52 Week Low | €5,550.00 |
Beta | 0.073 |
1 Month Change | 0.89% |
3 Month Change | -1.72% |
1 Year Change | -17.39% |
3 Year Change | 49.89% |
5 Year Change | 161.90% |
Change since IPO | 433.24% |
Recent News & Updates
Shareholder Returns
MDKA | HR Healthcare | HR Market | |
---|---|---|---|
7D | 0.9% | -2.7% | 1.7% |
1Y | -17.4% | 1.9% | 28.3% |
Return vs Industry: MDKA underperformed the HR Healthcare industry which returned 1.9% over the past year.
Return vs Market: MDKA underperformed the HR Market which returned 28.3% over the past year.
Price Volatility
MDKA volatility | |
---|---|
MDKA Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.2% |
Market Average Movement | 3.6% |
10% most volatile stocks in HR Market | 5.9% |
10% least volatile stocks in HR Market | 2.2% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine MDKA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1922 | 1,018 | Jasminko Herceg | www.medika.hr |
Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. The company primarily sells, stores, and distributes human and veterinary drugs, and equipment and dental supplies, as well as dietetic, cosmetic, hygienic, medicinal, and other products. It serves pharmacies, healthcare institutions, hospitals, health centers, outpatient facilities, doctor’s offices, wholesalers, and specialized stores; and dental practices, veterinary clinics, and medical centers, as well as herbal pharmacies, companies, optics, and others.
Medika d.d. Fundamentals Summary
MDKA fundamental statistics | |
---|---|
Market cap | €165.04m |
Earnings (TTM) | €20.23m |
Revenue (TTM) | €811.07m |
8.2x
P/E Ratio0.2x
P/S RatioIs MDKA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDKA income statement (TTM) | |
---|---|
Revenue | €811.07m |
Cost of Revenue | €746.12m |
Gross Profit | €64.96m |
Other Expenses | €44.72m |
Earnings | €20.23m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 698.83 |
Gross Margin | 8.01% |
Net Profit Margin | 2.49% |
Debt/Equity Ratio | 47.2% |
How did MDKA perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield29%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 04:41 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medika d.d. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|